We wish to thank the following organizations that are participating as exhibitors.

The materials they provide are independent of the CME program and not part of the CME educational materials. These entities did not influence or determine the content of AAP Colorado’s 2023 Annual Conference. Participation in the exhibits is optional and encouraged.

At Behavioral Innovations, we believe quality ABA therapy should be available to children who will benefit from this service. Applied behavior analysis or ABA therapy utilizes long-established principles of behavior therapy to identify and address the specific needs of children with autism or autism spectrum disorder (ASD).   For more than 20 years, the team at Behavioral Innovations has been guided by this mission to provide client-centered, evidence-based ABA therapy for children with autism in a nurturing learning environment.   We are trusted by parents and recommended by clinicians in all areas we serve.

The Colorado Immunization Branch, at the Colorado Department of Public Health and Environment, works to reduce vaccine-preventable disease by developing and implementing programs designed to positively influence the uptake of immunizations across the lifespan. The Immunization Branch utilizes a variety of strategies to promote education, optimize vaccine resources, assure access to vaccines and maintain the Colorado Immunization Information System (CIIS), a confidential, population-based, computerized information system that collects and consolidates immunization data for Coloradans of all ages from a variety of sources and provide tools for designing and sustaining effective immunization strategies at the provider and program levels. The Immunization Branch also operates the Federal Vaccines for Children (VFC) program, the Federal Section 317 program, and all immunization education and outreach activities. Learn more by visiting the organization’s website here

Colorado Pediatric Psychiatry Consultation & Access Program (CoPPCAP) provides consultation at no cost to pediatric care providers by licensed child & adolescent psychiatrists, psychologists, and specialized community resource navigators. Learn more by visiting the organization’s website here. Contact: Kristin Larpenter,  Info@coppcap.org, 1-888-910-0153.

GSK unites science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines.

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information contact Lori Amels at LAmels@sarepta.com, 559-287-2221, or visit www.sarepta.com.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company; our passion and pursuit of potentially life-changing treatments are rooted in our history. We know patients with rare diseases have spent their lives overcoming challenges. That’s why for 70+ years we’ve been working to support them in their fight. To learn more visit www.takeda.com or contact Jennifer.oberly@takeda.com or phone at (303) 802-0472.